Flatiron, Nationwide Most cancers Institute announce partnership and extra digital well being information

Megh

Flatiron, Nationwide Most cancers Institute announce partnership and extra digital well being information

Flatiron, Nationwide Most cancers Institute announce partnership and extra digital well being information

Healthtech firm Flatiron Well being is collaborating with NRG Oncology, a medical analysis consortium within the Nationwide Most cancers Institute’s Nationwide Scientific Trials Community with greater than 1,300 worldwide analysis websites, to deploy Flatiron Scientific Pipe in a multicenter NRG medical trial.

Flatiron Scientific Pipe is an digital well being report (EHR) to digital information seize (EDC) connector that goals to enhance effectivity and cut back effort and time of medical examine information entry.

The purpose of the collaboration is to broaden Flatiron Scientific Pipe use instances to incorporate NCTN-sponsored research by making use of Flatiron’s EHR-to-EDC expertise to cut back the burden on NRG medical trial website groups, streamline information administration and speed up examine timelines. 

NRG and Flatiron will conduct a correlative examine to evaluate the effectivity of Flatiron Scientific Pipe use in comparison with conventional information entry strategies.

“Collaborating with NRG Oncology, a number one analysis consortium throughout the Nationwide Scientific Trials Community, is an unimaginable alternative to create a brand new trial expertise, unlocking increased information high quality and extra environment friendly information acquisition with Flatiron Scientific Pipe,” Alex Deyle, basic supervisor of medical analysis at Flatiron Well being, mentioned in a press release. 

“By placing our cutting-edge expertise within the arms of extra analysis groups, Flatiron and NRG will improve our ongoing efforts to enhance effectivity and cut back effort and time of examine information seize, in the end accelerating proof era and enhancements in look after folks with most cancers.”


Healthcare AI platform Notable entered right into a multiyear partnership with CityMD, an pressing care supplier in New York and New Jersey. 

By way of the partnership, CityMD will leverage Notable’s AI and automation expertise at 180-plus websites with the purpose of bettering affected person entry, driving operational effectivity and lowering the executive burden related to walk-in care.

The alliance will see Notable’s AI platform and clever brokers driving automation throughout a number of use instances, together with pressing care scheduling, messaging, affected person registration and consumption and funds. 

“Pressing care is a important gateway to the healthcare system for thousands and thousands, but sufferers typically encounter pointless delays and obstacles to well timed care,” Pranay Kapadia, CEO of Notable, mentioned in a press release. 

“By bringing Notable’s AI-powered automation to CityMD, we’re addressing these challenges head-on. Our expertise streamlines each appointment, registration, and follow-up, guaranteeing that healthcare groups can function extra effectively regardless of staffing shortages.”


Bamboo Well being, a real-time care intelligence firm, introduced a partnership with the state of Ohio to bolster its prescription drug monitoring system, referred to as the Ohio Automated Rx Reporting System (OARRS).

The state expects to perform this by including a function straight of their present workflows that alerts healthcare suppliers if a affected person has a previous historical past of drug overdoses.

OD Insights is the most recent addition to Bamboo Well being’s Prescription Drug Monitoring Program suite and is geared toward bettering care coordination so emergency departments can steer high-risk sufferers to probably the most related therapy choices, together with entry to remedy for opioid use dysfunction and different instruments to forestall deadly overdoses.

In keeping with the corporate, by integrating seamlessly into OARRS, OD Insights provides well timed, pertinent information to assist medical decision-making whereas sustaining the identical protections afforded prescription information. 

Moreover, it permits suppliers to intently view a affected person’s managed substance use historical past on the level of care to assist knowledgeable prescribing practices as a part of a multidimensional response to the continued opioid epidemic.

“The Ohio Board of Pharmacy continues to be on the forefront of leveraging expertise to deal with the opioid epidemic,” Ross Armstrong, chief business officer at Bamboo Well being, mentioned in a press release. 

“We’re honored to accomplice with Ohio to implement OD Insights and consider this initiative will function a mannequin for different states seeking to broaden entry to hurt discount and therapy.”